Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events

Simple item page
dc.contributor.authorSozio, Margaret S.
dc.contributor.authorChalasani, Naga
dc.contributor.departmentDepartment of Medicine, IU School of Medicineen_US
dc.date.accessioned2016-10-25T17:58:39Z
dc.date.available2016-10-25T17:58:39Z
dc.date.issued2014-11
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationSozio, M. S., & Chalasani, N. (2014). Activated Recombinant Factor VIIa should not be used in patients with refractory variceal bleeding – it is mostly ineffective, is expensive, and may rarely cause serious adverse events. Hepatology (Baltimore, Md.), 60(5), 1786–1788. http://doi.org/10.1002/hep.27363en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/1805/11237
dc.language.isoen_USen_US
dc.publisherWiley Blackwell (John Wiley & Sons)en_US
dc.relation.isversionof10.1002/hep.27363en_US
dc.relation.journalHepatology (Baltimore, Md.)en_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectrecombinant Factor VIIaen_US
dc.subjectrFVIIaen_US
dc.subjectBleedingen_US
dc.subjectCirrhosisen_US
dc.titleActivated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse eventsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
nihms622667.pdf
Size:
39.82 KB
Format:
Adobe Portable Document Format
Description:
Author's manuscript
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works